✦ LIBER ✦

Cost-utility of velaglucerase alpha for the treatment of type I gaucher disease in Spain

✍ Scribed by Giraldo, P.; De La Serna, J.; Espinós, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS48 Cost-Utility of Denosumab for the

✍ J. Darba; L. Kaskens; F. Sorio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A 7-year open-label study of clinical pa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Cost-utility of ranolazine for the sympt

✍ Hidalgo-Vega, Álvaro; Ramos-Goñi, Juan Manuel; Villoro, Renata 📂 Article 📅 2013 🏛 Springer 🌐 French ⚖ 597 KB

Cost–Utility Analysis of Pancreas Transp

✍ V. Douzdjian; D. Ferrara; G. Silvestri 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 94 KB

PRM17 Cost-Utility Analysis of Donepezil

✍ Permsuwan, U.; Niwatananun, W.; Pimkrai, A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Changes of serum hexosaminidase for the

✍ Nakagawa, Sachiko ;Kumin, Selma ;Sachs, Gay ;Nitowsky, Harold M. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views